首页> Gut> Predictors of response to low-dose amitriptyline for irritable bowel syndrome and efficacy and tolerability according to subtype: post hoc analyses from the ATLANTIS trial.

Predictors of response to low-dose amitriptyline for irritable bowel syndrome and efficacy and tolerability according to subtype: post hoc analyses from the ATLANTIS trial.

导出 OA

翻译打印收藏纠错

第一作者： Alexandra,Wright-Hughes

第一单位： Clinical Trial Research Unit, Leeds Institute of Clinical Trials Research, School of Medicine, University of Leeds, Leeds, UK.

作者： Alexandra,Wright-Hughes ^[1] ; Pei-Loo,Ow ^[1] ; Sarah L,Alderson ^[2] ; Matthew J,Ridd ^[3] ; Robbie,Foy ^[2] ; Felicity L,Bishop ^[4] ; Matthew,Chaddock ^[5] ; Catherine,Fernandez ^[1] ; Elspeth A,Guthrie ^[2] ; Delia P,Muir ^[1] ; Christopher A,Taylor ^[1] ; Amanda J,Farrin ^[1] ; Hazel A,Everitt ^[6] ; Alexander C,Ford ^[7]

作者单位： Clinical Trial Research Unit, Leeds Institute of Clinical Trials Research, School of Medicine, University of Leeds, Leeds, UK. ^[1] Leeds Institute of Health Sciences, School of Medicine, University of Leeds, Leeds, UK. ^[2] Population Health Sciences, University of Bristol, Bristol, UK. ^[3] Centre for Clinical and Community Applications of Health Psychology, School of Psychology, University of Southampton, Southampton, UK. ^[4] Let's Cure IBS, Leeds, UK. ^[5] Primary Care and Population Sciences, University of Southampton, Southampton, UK. ^[6] Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, UK alexford@nhs.net.;Leeds Gastroenterology Institute, St James's University Hospital, Leeds, UK. ^[7]

关键词 ABDOMINAL PAIN IRRITABLE BOWEL SYNDROME